HUP9801241A2 - Vastagbélbe beadható, azathioprine tartalmú készítmények és eljárás előállításukra - Google Patents

Vastagbélbe beadható, azathioprine tartalmú készítmények és eljárás előállításukra

Info

Publication number
HUP9801241A2
HUP9801241A2 HU9801241A HUP9801241A HUP9801241A2 HU P9801241 A2 HUP9801241 A2 HU P9801241A2 HU 9801241 A HU9801241 A HU 9801241A HU P9801241 A HUP9801241 A HU P9801241A HU P9801241 A2 HUP9801241 A2 HU P9801241A2
Authority
HU
Hungary
Prior art keywords
azathioprine
compositions
preparation
colonic administration
active ingredient
Prior art date
Application number
HU9801241A
Other languages
English (en)
Inventor
William J. Sandborn
Original Assignee
Mayo Foundation For Medical Education And Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation For Medical Education And Research filed Critical Mayo Foundation For Medical Education And Research
Publication of HUP9801241A2 publication Critical patent/HUP9801241A2/hu
Publication of HUP9801241A3 publication Critical patent/HUP9801241A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgya eljárás alkálikűs adalékanyagtól mentes,gyűlladásős bélbetegségek kezelésére alkalmas, gyógyszerkészítményelőállítására, melynek sőrán a hatóanyagőt a gyűlladásős bélbetegségtüneteinek enyhítéséhez hatásős mennyiségű, ilyen kezelésre szőrűlóbeteg vastagbelébe való tőpikális alkalmazásra adaptált főrmájúazathiőprine-t használnak. A találmány kiterjed a fenti módőnelőállítőtt gyógyszerkészítményekre is. ŕ
HU9801241A 1995-03-30 1996-03-12 Azathioprine compositions for colonic administration and process for their preparation HUP9801241A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/413,505 US5691343A (en) 1995-03-30 1995-03-30 Use of topical azathioprine to treat inflammatory bowel disorders

Publications (2)

Publication Number Publication Date
HUP9801241A2 true HUP9801241A2 (hu) 1998-09-28
HUP9801241A3 HUP9801241A3 (en) 2000-06-28

Family

ID=23637470

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9801241A HUP9801241A3 (en) 1995-03-30 1996-03-12 Azathioprine compositions for colonic administration and process for their preparation

Country Status (18)

Country Link
US (2) US5691343A (hu)
EP (1) EP0817634A1 (hu)
JP (1) JPH11502842A (hu)
KR (1) KR19980703423A (hu)
AP (1) AP727A (hu)
AU (1) AU707168B2 (hu)
BR (1) BR9607964A (hu)
CA (1) CA2216728A1 (hu)
CZ (1) CZ290428B6 (hu)
EA (1) EA199700282A1 (hu)
HU (1) HUP9801241A3 (hu)
IS (1) IS4561A (hu)
NO (2) NO311491B1 (hu)
NZ (1) NZ306062A (hu)
OA (1) OA10517A (hu)
PL (1) PL322526A1 (hu)
TR (1) TR199701079T1 (hu)
WO (1) WO1996030021A1 (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028190A (en) 1994-02-01 2000-02-22 The Regents Of The University Of California Probes labeled with energy transfer coupled dyes
US6166024A (en) * 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
EP1017404B1 (en) * 1997-09-26 2004-06-23 Medeva Europe Limited Pharmaceutical composition for the treatment of inflammatory bowel disease
US6355623B2 (en) 1998-09-24 2002-03-12 Hopital-Sainte-Justine Method of treating IBD/Crohn's disease and related conditions wherein drug metabolite levels in host blood cells determine subsequent dosage
US7323471B1 (en) 1999-08-13 2008-01-29 Dor Biopharma, Inc. Topical azathioprine for the treatment of oral autoimmune diseases
US6689788B1 (en) 2000-08-25 2004-02-10 University Of Florida Method and composition for treatment of inflammatory bowel disease
US6946258B2 (en) 2002-03-04 2005-09-20 Biologix Diagnostics, Llc Rapid, immunochemical process for measuring thiopurine methyltransferase
IL152127A0 (en) * 2002-10-06 2003-05-29 Bio Balance Corp Probiotic compositions for the treatment of inflammatory bowel disease
US7067460B2 (en) 2002-11-14 2006-06-27 Baker Hughes Incorporated Organofunctional compounds for shale stabilization of the aqueous dispersed phase of non-aqueous based invert emulsion drilling system fluids
US8188067B2 (en) 2004-04-01 2012-05-29 Teva Pharmaceutical Industries Ltd. Formulations of 6-mercaptopurine
WO2005099666A2 (en) * 2004-04-01 2005-10-27 Teva Pharmaceutical Industries Ltd. Delayed release formulations of 6-mercaptopurine
US7923014B2 (en) * 2007-02-12 2011-04-12 The Board Of Regents Of The University Of Texas System Expression and purification of HIP/PAP and uses therefor
US7919251B2 (en) * 2007-10-12 2011-04-05 Guy's And St. Thomas' Nhs Foundation Trust Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy
WO2009128955A1 (en) * 2008-04-18 2009-10-22 Teva Pharmaceutical Industries Ltd. Treatment of inflammatory bowel disease with 6-mercaptopurine
US11077112B2 (en) 2015-09-29 2021-08-03 ProdrugXtend Pty Ltd Formulation and treatment methods
WO2017066619A1 (en) 2015-10-16 2017-04-20 Teva Pharmaceutical Industries Ltd. Treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis with delayed-release 6-mercaptopurine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3056785A (en) * 1960-03-21 1962-10-02 Burroughs Weilcome & Co U S A Purine derivatives
US4350690A (en) * 1980-10-27 1982-09-21 Cressington Investments Ltd. Steroid composition
US4627851A (en) * 1984-10-26 1986-12-09 Alza Corporation Colonic-therapeutic delivery system
JPS6272618A (ja) * 1985-09-27 1987-04-03 Kanji Takada アザチオプリン製剤
GB8812490D0 (en) * 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations
DK66493D0 (da) * 1993-06-08 1993-06-08 Ferring A S Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling

Also Published As

Publication number Publication date
NO311491B1 (no) 2001-12-03
AU5421896A (en) 1996-10-16
CZ309297A3 (cs) 1998-03-18
EP0817634A1 (en) 1998-01-14
NO20012930D0 (no) 2001-06-13
HUP9801241A3 (en) 2000-06-28
CZ290428B6 (cs) 2002-07-17
EA199700282A1 (ru) 1998-04-30
WO1996030021A1 (en) 1996-10-03
IS4561A (is) 1997-09-18
US5691343A (en) 1997-11-25
JPH11502842A (ja) 1999-03-09
US5905081A (en) 1999-05-18
AP9701098A0 (en) 1997-10-31
NO974440L (no) 1997-09-25
NO974440D0 (no) 1997-09-25
AP727A (en) 1999-01-29
NO20012930L (no) 1997-09-25
BR9607964A (pt) 1999-11-30
AU707168B2 (en) 1999-07-01
PL322526A1 (en) 1998-02-02
KR19980703423A (ko) 1998-11-05
MX9707391A (es) 1997-11-29
OA10517A (en) 2002-04-24
TR199701079T1 (xx) 1998-01-21
NZ306062A (en) 1998-10-28
CA2216728A1 (en) 1996-10-03

Similar Documents

Publication Publication Date Title
HUP9801241A2 (hu) Vastagbélbe beadható, azathioprine tartalmú készítmények és eljárás előállításukra
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
NO943151D0 (no) Tilstedeværende suppresjon av autoimmune sykdommer
FI20011852A (fi) Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
EA200601132A1 (ru) Предупреждение и лечение амилоидогенного заболевания
HUP9802234A2 (hu) Eljárás galantamin izolálására, valamint az ezt hatóanyagként tartalmazó gyógyszerkészítmények
HUP9602215A2 (hu) 4-Klór-5-(imidazolin-2-il-amino)-6-metoxi-2-metil-pirimidin alkalmazása megvonási tünetek kezelésére alkalmas gyógyszerkészítmény előállítására
CA2229282A1 (en) Use of hyaluronic acid as an immunosuppressant
TR200000369T2 (tr) Romatizmal hastalıkların tedavisinde kullanılmak üzere kombine farmasötik preparatların üretilmesi.
CA2433833A1 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependence
HK1079688A1 (en) Statin product for enhancing cognitive maintenance
WO1996030016A3 (en) Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases
HUP9901659A2 (hu) Flupirtin alkalmazása a hematopoetikus sejtrendszer károsodásával kapcsolatos megbetegedések megelőzésére és gyógyítására alkalmas gyógyszerkészítmény előállítására
EP0620737A1 (en) A THERAPEUTIC AGENT AGAINST RHEUMATISM CONTAINING LACTOFERRINE AND COSMETIC COMPOSITIONS CONTAINING SUCH AGENTS.
ES2180750T3 (es) Conjugado de un principio activo, un polieter y, en caso dado, una proteina nativa no considerada como exogena.
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
EA200400691A1 (ru) Получение чистых стереоизомеров трицикло[5,2,1,02,6]дец-9-ил-ксантогената и содержащие их лекарственные средства
FR2706303B1 (fr) Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.
MY131159A (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
ES2162040T3 (es) Utilizacion de un conjugado de un agente citostatico y albumina para producir medicamentos antiinflamatorios.
FR2707166B1 (fr) Utilisation de l'efaroxan et de ses dérivés pour la fabrication de médicaments destinés au traitement de maladies neurodégénératives et leur progression .
HUP0303754A2 (hu) Gyökfogó vegyületek alkalmazása NO-függő mikrokeringési zavarok kezelésére és megelőzésére szolgáló gyógyszerkészítmény előállítására
GEP20043356B (en) Compounds Useful For Treatment or Prevention of Diseases Mediated By Alpha- 2B-Adrenoceptor
TH25792A (th) สูตรผสมริโดเจรลขนาดต่ำ